Levine Jon R's Form 4 filing
Marimed Inc. (MRMD) · filed Apr 29, 2024
- Accession no.
- 0001522767-24-000031
- Filed
- Apr 29, 2024, 5:36 PM ET
- Trade date
- Apr 27-29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $12.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levine Jon RCIK 0001789645 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2024 | Common stock | MOption exerciseAcquired | +138,889 | $0.00F1 | $0 | 20,367,909 | Direct | |
| Apr 29, 2024 | Common stock | SSaleDisposed | −50,031 | $0.2553 | −$12,772.91 | 20,317,878 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 27, 2024 | Common Stock, par value $.001 per share | MOption exerciseDisposed | −138,889 | $0.00 | $0 | 416,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
RSUs convert to shares of common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.